previous compound ID: 1013 next compound
InChIKey: IWSWDOUXSCRCKW-UHFFFAOYSA-N
SMILES: COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "B Kus" "SD Macknight" "E Matthes" "R Robert" "GW Carlile" "J Goepp" "J Liao" "DY Thomas" "D Rotin"

chemical graph of compound 1013





CID is 44383
synonyms found at PubChem are:
Terazosin hydrochloride, 63074-08-8, Terazosin HCl, Hytrin, Vasocard, Abbott-45975, Zayasel, Terazosin hydrochloride anhydrous, (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride, MLS000040261, SMR000044015, DSSTox_CID_25493, DSSTox_RID_80913, DSSTox_GSID_45493, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride, 6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride, CAS-63074-08-8, 63590-64-7 (Parent), SR-01000000197, Prestwick_146, terazosine hydrochloride, Tetrazosin hydrochloride, Opera_ID_398, AC1L2BPY, NCGC00016903-01, SCHEMBL41545, MLS001077301, MLS001305722, C19H25N5O4.HCl, CHEMBL1256665, DTXSID7045493, KS-00000JKM, IWSWDOUXSCRCKW-UHFFFAOYSA-N, MolPort-003-666-790, HMS1570G04, Pharmakon1600-01505576, BCP12795, Terazosin monohydrochloride anhydrous, Tox21_110674, NSC759168, s4679, AKOS007930686, Tox21_110674_1, AC-2074, CCG-220751, LP01138, NE45355, NSC-759168, TRA0127916, VA11840, TERAZOSIN HYDROCHLORIDE (anhydrous), NCGC00016026-10, NCGC00094404-01, NCGC00094404-02, AN-14324, DS-11401, AB1009460, AB2000463, DB-018541, LS-110235, TL8004930, TR-037527, EU-0101138, FT-0605647, V1531, T 4680, Terazosin hydrochloride, >=98% (TLC), powder, 074T088, I06-0651, SR-01000000197-2, SR-01000000197-4, SR-01000000197-12, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine hydrochloride, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride, 2[4-(Tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline hydrochloride, 4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride, [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride, [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine Hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine hydrochloride, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-,monohydrochloride, AC1LD8ZY, AKOS026749822, [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone; hydron; chloride, MolPort-000-768-720, MCULE-4508839187